
Tredence acquired US-based KMK Consulting to expand its healthcare and life sciences business. The company expects the vertical to account for around 25% of overall revenue by 2028. KMK works with eight of the world's top 10 pharmaceutical companies, bringing commercial analytics and market access expertise.
Tap to vote and see what everyone thinks.
Summary by ByteBrief